We narrowed to 18,516 results for: MUT
- 
  Viral Prep#26976-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-hSyn-hChR2(H134R)-mCherry (#26976). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-mCherry plasmid DNA. Synapsin-driven, humanized channelrhodopsin H134R mutant, fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsmCherryAvailable SinceOct. 9, 2019AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-hSyn-hChR2(H134R)-mCherry (AAV8)Viral Prep#26976-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-hSyn-hChR2(H134R)-mCherry (#26976). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-mCherry plasmid DNA. Synapsin-driven, humanized channelrhodopsin H134R mutant, fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsmCherryAvailable SinceJan. 26, 2021AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-hSyn-hChR2(H134R)-EYFP (AAV2)Viral Prep#26973-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-hSyn-hChR2(H134R)-EYFP (#26973). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-EYFP plasmid DNA. hSyn-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEYFPAvailable SinceSept. 27, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-hChR2(H134R)-mCherry (AAV1)Viral Prep#26975-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-CaMKIIa-hChR2(H134R)-mCherry (#26975). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-mCherry plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsmCherryAvailable SinceFeb. 15, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  LARRYv2-mScarlet library 1Pooled Library#233697PurposeBarcoding pooled libraryDepositorSpeciesSyntheticUseLentiviralAvailable SinceMarch 6, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  LARRYv2-EGFP library 1Pooled Library#233215PurposeBarcoding pooled libraryDepositorSpeciesSyntheticUseLentiviralAvailable SinceMarch 6, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  LARRYv2-EGFP library 2Pooled Library#233216PurposeBarcoding pooled libraryDepositorSpeciesSyntheticUseLentiviralAvailable SinceMarch 6, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  LARRYv2-T-Sapphire library 1Pooled Library#233213PurposeBarcoding pooled libraryDepositorSpeciesSyntheticUseLentiviralAvailable SinceMarch 6, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  LARRYv2-T-Sapphire library 2Pooled Library#233214PurposeBarcoding pooled libraryDepositorSpeciesSyntheticUseLentiviralAvailable SinceMarch 6, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  
- 
  
- 
  EcNGRfEfC-fadD-tesA'Bacterial Strain#48938PurposeBase line strain is heat shock induce-able lambda red recombination system for MAGE (Multiplex Recombination Genome Engineering)DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M3E12Bacterial Strain#48930Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M3F12Bacterial Strain#48931Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M3G8Bacterial Strain#48932Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M3H7Bacterial Strain#48933Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M3H12Bacterial Strain#48934Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M1D4Bacterial Strain#48921Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M1E2Bacterial Strain#48922Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only
- 
  EcNGRfEfC-R6M1E6Bacterial Strain#48923Purposediversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.DepositorBacterial ResistanceSpectinomycinAvailable SinceDec. 3, 2014AvailabilityAcademic Institutions and Nonprofits only